MATERNAL SERUM SCREEN 2, ADVANCED REFLEX TO MBFD-21

The Maternal serum screen 2 Advance is a screen test done between 10-13 weeks of pregnancy has significant utility in Prenatal Screening of Down Syndrome Trisomy 21 . Using the dual approach the specificity of the test increases to >99% with a false positive rate of <0.05%.

  • Test Type:
  • Pre-test Information:
    Test is valid between 9-13 weeks gestation (Ideal 10-13 weeks). For Combined Risk Assessment (Biochemical risk + Nuchal translucency) kindly enclose Ultrasound report between 11-13 weeks gestation including CRL, NT & Nasal Bone. Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. Give clinical history on Maternal Serum Screen 2 reflex to MBFD-21 consent form (Form 12).
  • Report Delivery:
    Report : Dual test - Sample Mon through Sat by 9 am; Report Same day MBFD-21 - Sample by Tue 9 am; Report Next Tue
  • Components:
    0